Article Details

Morgan Stanley Increases Akero Therapeutics (NASDAQ:AKRO) Price Target to $40.00

Retrieved on: 2022-11-09 06:46:00

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Increases Akero Therapeutics (NASDAQ:AKRO) Price Target to $40.00. View article details on hiswai:

Excerpt

The firm currently has an “equal weight” rating on the stock. Morgan Stanley's price target suggests a potential upside of 3.98% from the stock's ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up